See more news releases in Banking & Financial Services | Real Estate | Commercial Real Estate | Dividends

BioMed Realty Trust Announces Tax Treatment Of 2012 Distributions

SAN DIEGO, Jan. 17, 2013 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the tax treatment of its 2012 distributions as follows:

Security Description: Common Stock CUSIP: 09063H107 Ticker Symbol: BMR
Record Date	Payable Date	Total Distribution Per Share	Allocable to 2012	Taxable Ordinary Dividend	Return of Capital	Long-Term Capital Gain	Unrecaptured Section 1250 Gain
12/30/2011	1/17/2012	$0.200000	$0.200000	$0.148244	$0.051756	$0.000000	$0.000000
3/30/2012	4/16/2012	$0.215000	$0.215000	$0.159362	$0.055638	$0.000000	$0.000000
6/29/2012	7/16/2012	$0.215000	$0.215000	$0.159362	$0.055638	$0.000000	$0.000000
9/28/2012	10/15/2012	$0.215000	$0.215000	$0.159362	$0.055638	$0.000000	$0.000000
Totals		$0.845000	$0.845000	$0.626330	$0.218670	$0.000000	$0.000000

Security Description: 7.375% Series A Cumulative Redeemable Preferred Stock CUSIP: 09063H206 Ticker Symbol: BMR PR A
Record Date	Payable Date	Total Distribution Per Share	Allocable to 2012	Taxable Ordinary Dividend	Return of Capital	Long-Term Capital Gain	Unrecaptured Section 1250 Gain
12/30/2011	1/17/2012	$0.460940	$0.460940	$0.460940	$0.000000	$0.000000	$0.000000
3/30/2012	4/16/2012	$0.460940	$0.460940	$0.460940	$0.000000	$0.000000	$0.000000
6/29/2012	7/16/2012	$0.460940	$0.460940	$0.460940	$0.000000	$0.000000	$0.000000
9/28/2012	10/15/2012	$0.460940	$0.460940	$0.460940	$0.000000	$0.000000	$0.000000
Totals		$1.843760	$1.843760	$1.843760	$0.000000	$0.000000	$0.000000

The distributions payable on January 15, 2013 to shareholders of record on December 31, 2012, as previously declared on December 12, 2012, are considered 2013 distributions for federal income tax purposes.

Stockholders are encouraged to consult with their personal tax advisors as to their specific tax treatment of BioMed Realty Trust distributions.

About BioMed Realty Trust

BioMed Realty delivers optimal real estate solutions for biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed Realty owns or has interests in properties comprising approximately 13.1 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Francisco, Maryland, San Diego, New York/New Jersey, Pennsylvania and Seattle, which have well-established reputations as centers for scientific research. Additional information is available at www.biomedrealty.com.